Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, highlights Emrelis’ potential to broaden its clinical impact by expanding into other solid tumors with high c-MET overexpression, beyond ...
Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how the approval of Emrelis is accelerating investor interest, validating biomarker-driven ADCs, and shaping distinct strategic ...
Under Neha Anand’s guidance, Three Layer Hospitality has become a frontrunner in the F&B market. It has ambitious plans for international expansion through partnerships and strategic alliances.
Neha Agrawal is an associate in Anand And Anand’s trademark department. She graduated with an LLB from Indraprastha University, New Delhi. Her main areas of practice are trademark, copyright, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results